Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo.

Human risk assessment for topical exposure requires percutaneous absorption data to link environmental contamination to potential systemic dose. Human absorption data are not readily available, so absorption models are used. In vitro diffusion systems are easy to use but have proved to be somewhat unreliable and are not validated to man. This study compares percutaneous absorption in the isolated perfused porcine skin flap (IPPSF) system with that in man in vivo. The study design utilized the same compounds and the same dose concentration and vehicle in both systems. Methodology for each system was that which is routinely used ineach system. The skin surface was not protected during the absorption dosing period. Percutaneous absorption values were, for man and the IPPSF system, respectively: salicylic acid (6.5 +/- 5.0%; 7.5 +/- 2.6%), theophylline (16.9 +/- 11.3%; 11.8 +/- 3.8%), 2,4-dimethylamine (1.1 +/- 0.3%; 3.8 +/- 0.6%), diethyl hexyl phthalic acid (1.8 +/- 0.5%; 3.9 +/- 2.4%), and p-aminobenzoic acid (11.5 +/- 6.3%; 5.9 +/- 3.7%) (correlation coefficient was 0.78; p < 0.04). The skin surface wash recovery postapplication was similar for salicylic acid in man (53.4 +/- 6.3%) and the IPPSF system (48.2 +/- 4.9%). With the other compounds the majority of surface chemical was recovered in the surface wash and skin tape strip in the IPPSF system. With man, other than salicylic acid, only a few percent applied dose was recovered with surface washing and tape stripping. Since the wash procedure was effective with pig skin, we can assume that these chemicals in man were lost to adsorption to any clothing or bedding with the volunteers. The absorption in man was not less than that in the IPPSF. Assuming the dose was lost in man, it seems plausible that whatever compound was to penetrate human skin in solvent vehicle did so in the period of time before the chemical was removed. The IPPSF system appears to be a good model for predicting percutaneous absorption relative to man. This study design should be used to validate other systems to humans in vivo.

[1]  H. Maibach,et al.  Dermal absorption of the phenoxy herbicides 2,4-D, 2,4-D amine, 2,4-D isooctyl, and 2,4,5-T in rabbits, rats, rhesus monkeys, and humans: a cross-species comparison. , 1990, Journal of toxicology and environmental health.

[2]  H I Maibach,et al.  In vivo and in vitro percutaneous absorption and skin evaporation of isofenphos in man. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[3]  H. Maibach,et al.  Absorption of some organic compounds through the skin in man. , 1970, The Journal of investigative dermatology.

[4]  N. Monteiro-Riviere,et al.  Development of surgical techniques for preparation of in vitro-isolated perfused porcine skin flaps for percutaneous absorption studies. , 1991, American journal of veterinary research.

[5]  H. Maibach,et al.  Dermal absorption of the phenoxy herbicide 2,4-D dimethylamine in humans: effect of DEET and anatomic site. , 1992, Journal of toxicology and environmental health.

[6]  N. Monteiro-Riviere,et al.  The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. , 1991, Critical reviews in toxicology.

[7]  H. Maibach,et al.  Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. , 1983, Drug metabolism reviews.

[8]  H. Schaefer,et al.  In vivo correlation between stratum corneum reservoir function and percutaneous absorption. , 1983, The Journal of investigative dermatology.

[9]  H I Maibach,et al.  Skin permeability in vivo: comparison in rat, rabbit, pig and man. , 1972, The Journal of investigative dermatology.

[10]  P. Williams,et al.  Quantitative prediction of transdermal iontophoretic delivery of arbutamine in humans with the in vitro isolated perfused porcine skin flap. , 1992, Journal of pharmaceutical sciences.